PubRank

M López-Botet

Author PubWeight™ 75.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997 3.57
2 HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 1998 3.35
3 Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 1997 2.89
4 Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988 2.08
5 Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999 1.70
6 The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997 1.69
7 The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999 1.64
8 HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 1998 1.60
9 The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997 1.58
10 Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur J Immunol 1988 1.46
11 Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies. J Immunol 1982 1.45
12 Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995 1.40
13 Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies. J Immunol 1988 1.39
14 CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J Immunol 1997 1.30
15 Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 1995 1.28
16 A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999 1.18
17 A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1990 1.17
18 Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol 1998 1.15
19 Removal of PHA from supernatants containing T-cell growth factor. J Immunol Methods 1981 1.12
20 Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology 1990 1.10
21 Induction of natural killer-like cytotoxicity in cultured human thymocytes. Eur J Immunol 1983 1.09
22 The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J Cell Biol 2000 1.09
23 NK cell receptors involved in the response to human cytomegalovirus infection. Curr Top Microbiol Immunol 2006 1.07
24 Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J Immunol 1994 1.07
25 Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression. J Immunol 1982 1.05
26 Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol 1996 1.02
27 An in vivo functional immune system lacking polyclonal T-cell surface expression of the CD3/Ti(WT31) complex. Scand J Immunol 1987 0.97
28 Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 1996 0.96
29 Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur J Immunol 1998 0.96
30 The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995 0.95
31 Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells. Eur J Immunol 1993 0.93
32 Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood 1998 0.93
33 Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. Chest 1993 0.92
34 Roles of chemokines and receptor polarization in NK-target cell interactions. J Immunol 1998 0.92
35 A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 1991 0.92
36 Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines. J Immunol 1981 0.91
37 Induction of T cell function via the gp33/27 activation inducer molecule (AIM) requires co-expression of the CD3/TcR complex. Eur J Immunol 1989 0.91
38 Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Genes Immun 2009 0.89
39 Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun 2007 0.87
40 Familial defect of CD3 (T3) expression by T cells associated with rare gut epithelial cell autoantibodies. Lancet 1986 0.87
41 Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon. Hepatology 1993 0.85
42 The human natural killer gene complex is located on chromosome 12p12-p13. Immunogenetics 1997 0.85
43 Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. Clin Immunol 2011 0.85
44 Expression and function of alpha 4/beta 7 integrin on human natural killer cells. Immunology 1996 0.85
45 In vitro immune cell function in six cases of immunoproliferative small intestinal disease after long term remission. Clin Exp Immunol 1983 0.85
46 Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. Immunology 1989 0.84
47 Deficient protein kinase C-dependent Na+/H+ exchanger activity in T cells from bone marrow transplantation recipients. J Immunol 1989 0.82
48 Structure of the human CD94 C-type lectin gene. Immunogenetics 1998 0.82
49 Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-alpha production involving the LFA-1 integrin. J Immunol 1993 0.82
50 Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 1991 0.81
51 Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J Immunol 1999 0.81
52 Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy. Clin Immunol 2010 0.81
53 Circulating NK-cell subsets in renal allograft recipients with anti-HLA donor-specific antibodies. Am J Transplant 2015 0.80
54 Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantation. Eur J Immunol 1987 0.80
55 CD2 is involved in regulating cyclic AMP levels in T cells. Eur J Immunol 1988 0.79
56 Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol 2001 0.79
57 Functional analysis of alpha 1 beta 1 integrin in human natural killer cells. Eur J Immunol 1996 0.79
58 Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E. Eur J Immunol 2000 0.79
59 Natural killer-like cytotoxicity of human T-cell clones against various target cells. Scand J Immunol 1983 0.78
60 Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens 2012 0.78
61 Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation. Clin Exp Immunol 1990 0.78
62 Phospholipase D activation in human natural killer cells through the Kp43 and CD16 surface antigens takes place by different mechanisms. Involvement of the phospholipase D pathway in tumor necrosis factor alpha synthesis. J Exp Med 1992 0.78
63 Cyclic AMP and calcium regulate at a transcriptional level the expression of the CD7 leukocyte differentiation antigen. J Biol Chem 1992 0.77
64 A novel functional cell surface dimer (kp43) serves as accessory molecule for the activation of a subset of human gamma delta T cells. J Immunol 1993 0.77
65 NK cell mediated recognition of HLA class Ib molecules: role of CD94/NKG2 receptors. J Reprod Immunol 1999 0.77
66 A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. Curr Top Microbiol Immunol 1999 0.76
67 [Production of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages from patients with rheumatoid arthritis and interstitial pulmonary disease]. Arch Bronconeumol 1997 0.75
68 Analysis of different protein kinase C-dependent events in T cells from allogeneic bone marrow transplantation recipients. Clin Exp Immunol 1992 0.75
69 Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins. Clin Exp Immunol 1988 0.75
70 Functional analysis of peripheral blood lymphocytes isolated from patients with chronic hepatitis type B. Dig Dis Sci 1992 0.75
71 Interleukin 2 and interferon-gamma are not sufficient to induce natural killer-like activity in human T cell clones. Eur J Immunol 1984 0.75
72 High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients. Haematologica 2001 0.75
73 Intrahepatic enhanced expression of beta2-microglobulin conformational epitope in acute liver allograft rejection: evidence of modulation by glucocorticoids. Dig Dis Sci 1998 0.75
74 High toxic efficiency of ricin immunotoxins specific for the T-cell antigen receptor of a human leukemia T-cell line. Int J Cancer 1989 0.75
75 Costimulation of cAMP and protein kinase C pathways inhibits the CD3-dependent T cell activation and leads to a persistent expression of the AP-1 transcription factor. Cell Immunol 1993 0.75